Bilateral Warthin tumor in psoriatic patients in therapy with multiple immunosuppressive therapy.

Abstract

Anti-TNFα drugs have strongly changed the way in which we deal with moderate and severe psoriasis. However, it is debatable whether biological drugs could increase the risk of developing cancer. The correlation between anti-TNFα drugs and lymphomas is well-known and is reported in all the technical details of biologic drugs. However, the association between anti-TNFα agents and solid tumors is still controversial. The authors report a case of bilateral salivary gland tumor in a psoriatic patient treated with several immunosuppressive therapies including anti-TNFα inhibitors.

• Authors: M Burlando, E Cozzani, C Chinazzo, M Larosa, M Boggio, A Parodi
• Journal: International journal of immunopathology and pharmacology (Int J Immunopathol Pharmacol) Vol. 28 Issue 1 Pg. 138-41 (Mar 2015) ISSN: 0394-6320 [Print] England
• PMID: 25816418 (Publication Type: Case Reports, Letter)
• Copyright: © The Author(s) 2015.

Chemical References

• Antibodies, Monoclonal
• Antirheumatic Agents
• Immunosuppressive Agents
• Tumor Necrosis Factor-alpha

Topics

• Antibodies, Monoclonal (adverse effects, therapeutic use)
• Antirheumatic Agents (adverse effects, therapeutic use)
• Humans
• Immunosuppressive Agents (adverse effects, therapeutic use)
• Male
• Middle Aged
• Psoriasis (drug therapy)
• Tumor Necrosis Factor-alpha (antagonists & inhibitors)
• Wilms Tumor (chemically induced)